Abstract: An electronic device including first and second housings rotated on a hinge unit, a display exposed to an outside through the first and second housings, first and second cameras disposed respectively in the first and second housings, at least one sensor, and at least one processor, is provided. The at least one processor is configured to obtain first and second images using the first camera and second cameras, respectively, generate a first panoramic image based on the first and second images, detect a rotation of at least one of the first housing or the second housing through the hinge unit using the at least one sensor, obtain at least one image using at least one of the first or second cameras while the at least one housing rotates, and generate a second panoramic image based on the first panoramic image and the at least one image.

Abstract: An electronic device including first and second housings rotated on a hinge unit, a display exposed to an outside through the first and second housings, first and second cameras disposed respectively in the first and second housings, at least one sensor, and at least one processor, is provided. The at least one processor is configured to obtain first and second images using the first camera and second cameras, respectively, generate a first panoramic image based on the first and second images, detect a rotation of at least one of the first housing or the second housing through the hinge unit using the at least one sensor, obtain at least one image using at least one of the first or second cameras while the at least one housing rotates, and generate a second panoramic image based on the first panoramic image and the at least one image.

Abstract: A playground system includes a playground appliance and a processing unit. The processing unit is adapted to receive a sensor signal from the sensor indicative of the detected movement, and to control the display to indicate a user-selection responsive to the received sensor signal.

Abstract: A playground system includes a playground appliance and a processing unit. The processing unit is adapted to receive a sensor signal from the sensor indicative of the detected movement, and to control the display to indicate a user-selection responsive to the received sensor signal.

Abstract: The present invention discloses and describes pluripotent homozygous stem (HS) cells, and methods and materials for making same. The present invention also provides methods for differentiation of HS cells into progenitor (multipotent) cells or other desired cells, groups of cells or tissues. Further, the applications of the HS cells disclosed herein, include (but are not limited to) the diagnosis and treatment of various diseases (for example, genetic diseases, neurodegenerative diseases, endocrine-related disorders and cancer), traumatic injuries, cosmetic or therapeutic transplantation, gene therapy and cell replacement therapy.

Abstract: A method of producing a homogenous population of homozygous stem (HS) cells pre-selected for immunotype and/or genotype from donor cells is described herein. The invention relates to methods of using immunohistocompatible HS cells for diagnosis, therapeutic and cosmetic transplantation, and the treatment of various genetic diseases, neurodegenerative diseases, traumatic injuries and cancer. The invention further relates to methods for using histocompatible HS stem cells pre-selected for a non-disease genotype for prophylactic and therapeutic intervention including, but not limited to, therapeutic and cosmetic transplantation, and the treatment of various genetic diseases, neurodegenerative diseases, and cancer.

Abstract: A method of producing a homogenous population of homozygous stem (HS) cells pre-selected for immunotype and/or genotype from donor cells is described herein. The invention relates to methods of using immunohistocompatible HS cells for diagnosis, therapeutic and cosmetic transplantation, and the treatment of various genetic diseases, neurodegenerative diseases, traumatic injuries and cancer. The invention further relates to methods for using histocompatible HS stem cells pre-selected for a non-disease genotype for prophylactic and therapeutic intervention including, but not limited to, therapeutic and cosmetic transplantation, and the treatment of various genetic diseases, neurodegenerative diseases, and cancer.

Abstract: The present invention discloses and describes pluripotent homozygous stem (HS) cells, and methods and materials for making same. The present invention also provides methods for differentiation of HS cells into progenitor (multipotent) cells or other desired cells, groups of cells or tissues. Further, the applications of the HS cells disclosed herein, include (but are not limited to) the diagnosis and treatment of various diseases (for example, genetic diseases, neurodegenerative diseases, endocrine-related disorders and cancer), traumatic injuries, cosmetic or therapeutic transplantation, gene therapy and cell replacement therapy.

Abstract: The present invention discloses and describes pluripotent homozygous stem (HS) cells, and methods and materials for making same. The present invention also provides methods for differentiation of HS cells into progenitor (multipotent) cells or other desired cells, groups of cells or tissues. Further, the applications of the HS cells disclosed herein, include (but are not limited to) the diagnosis and treatment of various diseases (for example, genetic diseases, neurodegenerative diseases, endocrine-related disorders and cancer), traumatic injuries, cosmetic or therapeutic transplantation, gene therapy and cell replacement therapy.

Abstract: A method of producing a homogenous population of homozygous stem (HS) cells pre-selected for immunotype and/or genotype from donor cells is described herein. The invention relates to methods of using immunohistocompatible HS cells for diagnosis, therapeutic and cosmetic transplantation, and the treatment of various genetic diseases, neurodegenerative diseases, traumatic injuries and cancer. The invention further relates to methods for using histocompatible HS stem cells pre-selected for a non-disease genotype for prophylactic and therapeutic intervention including, but not limited to, therapeutic and cosmetic transplantation, and the treatment of various genetic diseases, neurodegenerative diseases, and cancer.